MedPath
NMPA Approval

Naloxone Hydrochloride for Injection

国药准字H20061216

December 14, 2020

国药准字H20061216

Drug Information

注射用盐酸纳洛酮

注射剂(注射用无菌粉末)

4mg

化学药品

December 14, 2020

Company Information

Applicant Company

成都高新区西源大道8号

Manufacturing Company

成都高新区西源大道8号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

注射用盐酸纳洛酮 - NMPA 批准文号 | MedPath